| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |